Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPAVmed Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$7.52 | -$5.08 | -$6.30 |
| Q2 2026 | 1 | -$9.32 | -$6.28 | -$7.80 |
| Q3 2026 | 1 | -$6.09 | -$4.11 | -$5.10 |
| Q4 2026 | 1 | -$5.73 | -$3.87 | -$4.80 |
PAVmed Inc Earnings Date And Information
PAVmed Inc last posted its earnings results on Thursday, November 13th, 2025. The company reported $-8.41 earnings per share for the quarter, missing analysts' consensus estimates of $-6.01 by $2.4. The company had revenue of 5.00 K for the quarter and had revenue of 3.00 M for the year. PAVmed Inc has generated $99 earnings per share over the last year ($14.883 diluted earnings per share) and currently has a price-to-earnings ratio of 2.27. PAVmed Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
PAVmed Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2025 | Q3 2025 | N/A | -$8.70 | N/A | $12.50 K | $5.00 K |
| 08/13/2025 | Q2 2025 | -$0.25 | -$22.20 | -21.95 | $10.00 K | $6.00 K |
| 05/14/2025 | Q1 2025 | -$0.29 | $38.26 | 38.55 | N/A | $8.00 K |
| 03/24/2025 | Q4 2024 | N/A | $3.61 | N/A | N/A | $10.00 K |
| 11/13/2024 | Q3 2024 | N/A | $192.84 | N/A | $1.09 M | $996.00 K |
| 08/12/2024 | Q2 2024 | N/A | -$35.75 | N/A | $1.20 M | $979.00 K |
| 05/13/2024 | Q1 2024 | -$1.67 | -$78.62 | -76.95 | N/A | $1.01 M |
| 03/25/2024 | Q4 2023 | N/A | -$58.07 | N/A | N/A | $1.05 M |
| 11/13/2023 | Q3 2023 | N/A | -$71.35 | N/A | N/A | $791.00 K |
| 08/14/2023 | Q2 2023 | N/A | -$63.01 | N/A | N/A | $166.00 K |
| 05/15/2023 | Q1 2023 | N/A | -$83.45 | N/A | N/A | $446.00 K |
| 03/13/2023 | Q4 2022 | -$0.25 | -$97.76 | -97.51 | N/A | $112.00 K |
| 11/14/2022 | Q3 2022 | N/A | -$131.34 | N/A | N/A | $76.00 K |
| 08/15/2022 | Q2 2022 | N/A | -$132.45 | N/A | N/A | $0 |
| 05/16/2022 | Q1 2022 | N/A | -$88.30 | N/A | N/A | $189.00 K |
| 04/05/2022 | Q4 2021 | N/A | -$90.06 | N/A | N/A | $300.00 K |
| 11/22/2021 | Q3 2021 | -$0.13 | -$66.41 | -66.28 | N/A | $200.00 K |
| 08/16/2021 | Q2 2021 | N/A | -$63.18 | N/A | N/A | $0 |
| 05/17/2021 | Q1 2021 | -$0.12 | -$57.84 | -57.72 | N/A | $0 |
| 03/15/2021 | Q4 2020 | N/A | -$76.77 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
PAVmed Inc Earnings: FAQ's
The conference call for PAVmed Inc's latest earnings report can be listened to online.
The conference call transcript for PAVmed Inc's latest earnings report can be read online.
PAVmed Inc (:PAVM) has a recorded annual revenue of $3.00 M.
PAVmed Inc (:PAVM) has a recorded net income of $39.79 M.PAVmed Inc has generated $99.147 earnings per share over the last four quarters.
PAVmed Inc (:PAVM) has a price-to-earnings ratio of 2.27 and price/earnings-to-growth ratio is -0.02.